18/06/2026
Can a single injection provide months of disease control for wet AMD and DME?
New data presented at Retina World Congress 2026 highlight the potential of EYP-1901, a sustained-release intravitreal insert designed to reduce treatment burden while maintaining vision outcomes.
“Patients are often undertreated, driven in part by the high burden of frequent intravitreal injections and high rate of discontinuation, underscoring a need for more durable treatment options.”
🔗 Read more: https://ow.ly/txie50Z7wtS